Spinal cord regeneration using human marrow stromal cells
Spinal cord regeneration using human marrow stromal cells
批准号:
17591562
负责人:
MATSUYAMA Yukihiro
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
摘要1人骨髓基质细胞是一种具有吸引力的自体细胞和基因治疗的来源。在本研究中,我们开发了一种高效的hMSCs转染方法。尽管非病毒载体往往表现出有效的递送,但它们在基因治疗中提供了优于病毒载体的几个优势。将编码绿色荧光蛋白组分的质粒pEGFP-N1通过核转染和电穿孔两种非病毒方法转染hMSCs和大鼠骨髓基质细胞。核转染法比电穿孔法具有更高的转染率,尤其是在hMSCs中。摘要2我们研究了软骨素酶ABC对轴突再生的影响。我们比较了15 mm胫神经切除和修复后的轴突再生与填充有I型胶原凝胶的硅胶管(阴性对照组),填充有含有三种不同浓度(2.5u/ml,5 u/ml,10 u/ml)的软骨素酶ABC的I型胶原凝胶的硅胶管(软骨素酶ABC组),以及自体神经段(自体神经移植组)。术后12周行神经电生理和组织学检查,除阴性对照组外,其余各组均记录复合动作电位(CMAP)和神经传导速度(NCV)。虽然CMAP和NCV在自体神经移植组中最高,但三个软骨素酶ABC组在任一参数上均无显著差异。组织学结果与电生理结果一致。我们的结论是,局部注射软骨素酶ABC可以显着增加神经管化或人工神经放置的神经缺损修复的临界长度。
英文摘要
Abstract 1Human marrow stromal cells(hMSCs) are an attractive source for autologous cell and gene therapies. In this study, we developed a highly efficient transfection method for hMSCs. Although they tend to show efficient delivery, nonviral vectors offer several advantages over viral vectors for gene therapies. hMSCs and rat marrow stromal cells were transfected with the plasmid pEGFP-N1 that encoded a green fluorescent protein component by using two nonviral methods : nucleofection and electroporation. Nucleofection provided a much better rate of transfer than electroporation particularly in hMSCs.Abstract 2we evaluated the effects of chondroitinase ABC on axonal regeneration across peripheral nerve gaps. We compared axonal regeneration after 15 mm tibial nerve resection and repair with a silicone tube filled with type I collagen gel (negative control group),with a silicone tube filled with type I collagen gel containing chondroitinase ABC at three different concentrations (2.5u/ml, 5u/ml, 10 u/ml) (chondroitinase ABC groups), and with an autologous nerve segment (nerve autograft group). Electrophysiological and histological assessments were carried out 12 weeks after surgery.Compound action potentials (CMAPs) and nerve conduction velocities (NCVs) were recorded in all groups but the negative control group. Although both CMAPs and NCVs were highest in the nerve autograft group, there were no significant differences among the three chondroitinase ABC groups in either parameter. Histological findings were consistent with electrophysiological results. We conclude that topical injection of chondroitinase ABC can significantly increase the critical length of nerve gap repair by tubulization or artificial nerve placement.
期刊论文(37)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Comparison of surgical outcomes between macro discectomy and micro discectomy for lumbar disc hemiation : a prospective randomized study with surgery performed by the same spine surgeon
腰椎间盘突出症的大椎间盘切除术和显微椎间盘切除术的手术结果比较:由同一位脊柱外科医生进行手术的前瞻性随机研究
DOI:
--
发表时间:
2006
期刊:
J Spinal Disord Tech. 19(5)
影响因子:
--
作者:
[Yoshito Katayama, Yukihiro Matsuyama, Hisatake Yoshihara, Yoshihito Sakai, Hiroshi Nakamura, Syojiro Nakashima, Zenya Ito, Naoki Ishiguro]
通讯作者:
Naoki Ishiguro
Surgical Treatment for ossification of the Posterior Longitudinal Ligament of the Thoracic Spine : Outcomes of One-Stage Posterior Decompression with Corrective Fusion Surgery, OPLL - Ossification of the Posterior Longitudinal Ligament
胸椎后纵韧带骨化的手术治疗:一期后路减压与矫正融合手术的结果,OPLL - 后纵韧带骨化
DOI:
--
发表时间:
2006
期刊:
Springer 2^<nd> Edition
影响因子:
--
作者:
[Tatsuya Hattori, Yukihiro Matsuyama, Yoshihito Sakai, Naoki Ishiguro, Hitoshi Hirata, Yukihiro Matsuyama, Yukihiro Matsuyama]
通讯作者:
Yukihiro Matsuyama
DOI:
10.1097/01.bsd.0000127700.29969.e6
发表时间:
2005-02-01
期刊:
JOURNAL OF SPINAL DISORDERS & TECHNIQUES
影响因子:
--
作者:
[Matsuyama, Y, Kawakami, N, Ishiguro, N]
通讯作者:
Ishiguro, N
Expression of GDNF in spinal cord injury and its repression by ONO-1714
GDNF 在脊髓损伤中的表达及其 ONO-1714 的抑制
DOI:
--
发表时间:
2005
期刊:
Neuroreport 16
影响因子:
--
作者:
[Yoshihito Sakai, Yukihiro Matsuyama, Hisatake Yoshihara, Hiroshi Nakamura, Naoki Ishiguro, Yukihiro Matsuyama, Hisatake Yoshihara, Takuya Yamamoto, Tetsuo Masui, Syojiro Nakashima, Yukihiro Matsuyama, Syojiro Nakashima, Shojiro Nakashima]
通讯作者:
Shojiro Nakashima
DOI:
10.1097/01.bsd.0000155033.63557.9c
发表时间:
2005-12-01
期刊:
JOURNAL OF SPINAL DISORDERS & TECHNIQUES
影响因子:
--
作者:
[Matsuyama, Y, Yoshihara, H, Ishiguro, N]
通讯作者:
Ishiguro, N
共 21 条
Pathology & treatment of spinal cord injury
-
批准号:24592192
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2012
-
负责人:MATSUYAMA Yukihiro
-
依托单位:
Spinal cord regeneration with infusion of ch-ABC and transplantation of bone marrow stem cells
-
批准号:19591718
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2007
-
负责人:MATSUYAMA Yukihiro
-
依托单位:
Clinical application of Cartilage-derived Retinoic Acid-sensitive Protein in Orthopaedic Surgery
-
批准号:14571373
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:2002
-
负责人:MATSUYAMA Yukihiro
-
依托单位:
Gene TheraphyforSpinal Cord Injury
-
批准号:12671407
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2000
-
负责人:MATSUYAMA Yukihiro
-
依托单位:
国内基金
海外基金
登录
查看更多内容
双靶向CSPG4/CD126嵌合抗原受体修饰的复制缺失型弓形虫减毒活疫苗(CAR-Tg)抗恶性黑色素瘤的效应及机制研究
-
批准号:32370997
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:卓洵辉
-
依托单位:
CSPG4 在子痫前期胎盘病理发生中的作用及机制研究
-
批准号:2021JJ30547
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:张居作
-
依托单位:
KDELR通过ArfGAP3调控CSPG4囊泡转运介导胶质瘤耐药的药理研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2021
-
负责人:李宗阳
-
依托单位:
周细胞高尔基体形变调控CSPG4膜转位在烟雾病出血中的分子机制
-
批准号:82171332
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2021
-
负责人:王霞
-
依托单位:
CSPG4/NG2促进甲状腺癌细胞对BRAFV600E激酶抑制剂耐药的机制研究
-
批准号:82072949
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:侯鹏
-
依托单位:
联合干预Vim和CSPG对大鼠脊髓胶质瘢痕的影响
-
批准号:30471781
-
项目类别:面上项目
-
资助金额:20.0万元
-
批准年份:2004
-
负责人:林江凯
-
依托单位:
CSPG对初级传入轴突在脊髓内生长的调节及机制
-
批准号:30270438
-
项目类别:面上项目
-
资助金额:19.0万元
-
批准年份:2002
-
负责人:武胜昔
-
依托单位: